These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 32996041

  • 1. LINC00657 knockdown suppresses hepatocellular carcinoma progression by sponging miR-424 to regulate PD-L1 expression.
    Cao X, Zhang G, Li T, Zhou C, Bai L, Zhao J, Tursun T.
    Genes Genomics; 2020 Nov; 42(11):1361-1368. PubMed ID: 32996041
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B, Cai H, Zheng R, Yang S, Zhou Z, Tu J.
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q, Zhang W, Wang Z, Liu S.
    BMC Cancer; 2019 Jul 24; 19(1):731. PubMed ID: 31340767
    [Abstract] [Full Text] [Related]

  • 4. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 5. LINC00657 activates PD-L1 to promote osteosarcoma metastasis via miR-106a.
    Zhang J, Chou X, Zhuang M, Zhu C, Hu Y, Cheng D, Liu Z.
    J Cell Biochem; 2020 Oct 19; 121(10):4188-4195. PubMed ID: 31898338
    [Abstract] [Full Text] [Related]

  • 6. Long Noncoding RNA HOTAIR Contributes to Progression in Hepatocellular Carcinoma by Sponging miR-217-5p.
    Gong X, Zhu Z.
    Cancer Biother Radiopharm; 2020 Jun 19; 35(5):387-396. PubMed ID: 32315535
    [Abstract] [Full Text] [Related]

  • 7. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
    Zhao H, Xie Z, Tang G, Wei S, Chen G.
    J Cell Physiol; 2020 Oct 19; 235(10):6990-7002. PubMed ID: 31994189
    [Abstract] [Full Text] [Related]

  • 8. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W, Chen X, Chi W, Xue M.
    Int J Mol Med; 2020 Nov 19; 46(5):1743-1754. PubMed ID: 33000222
    [Abstract] [Full Text] [Related]

  • 9. HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis.
    Zeng C, Ye S, Chen Y, Zhang Q, Luo Y, Gai L, Luo B.
    J Immunol Res; 2021 Nov 19; 2021():9289719. PubMed ID: 34988230
    [Abstract] [Full Text] [Related]

  • 10. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
    Guo D, Li Y, Chen Y, Zhang D, Wang X, Lu G, Ren M, Lu X, He S.
    Cell Prolif; 2019 Jul 19; 52(4):e12628. PubMed ID: 31038266
    [Abstract] [Full Text] [Related]

  • 11. LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma.
    Yeermaike A, Gu P, Liu D, Nadire T.
    Mamm Genome; 2022 Sep 19; 33(3):525-533. PubMed ID: 35357550
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H, Ke J, Guo Q, Barnabo Nampoukime KP, Yang P, Ma K.
    J Cell Mol Med; 2018 Dec 17; 22(12):5862-5876. PubMed ID: 30246921
    [Abstract] [Full Text] [Related]

  • 14. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J, Li T, Han X, Yuan H.
    J Cancer Res Clin Oncol; 2018 Feb 17; 144(2):205-214. PubMed ID: 29127494
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S, Tang Z, Chen K, Liu Y, Yu G, Chen Q, Dang H, Chen F, Ling J, Zhu L, Huang A, Tang H.
    J Exp Clin Cancer Res; 2018 Sep 03; 37(1):214. PubMed ID: 30176933
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
    Zhang W, Liu S, Liu K, Liu Y.
    J Cell Mol Med; 2019 Aug 03; 23(8):5154-5164. PubMed ID: 31207081
    [Abstract] [Full Text] [Related]

  • 17. Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR-5095 from MBD2.
    E C, Li C, Li H, Yang J.
    J Cell Physiol; 2019 Aug 03; 234(10):18504-18512. PubMed ID: 30912130
    [Abstract] [Full Text] [Related]

  • 18. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
    Huang D, Bi C, Zhao Q, Ding X, Bian C, Wang H, Wang T, Liu H.
    BMC Cancer; 2018 Sep 24; 18(1):919. PubMed ID: 30249208
    [Abstract] [Full Text] [Related]

  • 19. LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 axis.
    Hu WY, Wei HY, Li KM, Wang RB, Xu XQ, Feng R.
    Biomed Pharmacother; 2020 Jan 24; 121():109642. PubMed ID: 31731191
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H, Zhu Z, Wang X, Jin S.
    J Exp Clin Cancer Res; 2020 Aug 14; 39(1):159. PubMed ID: 32795316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.